NPI: 1407801640 · WEST ALLIS, WI 53227 · General Acute Care Hospital · NPI assigned 05/24/2006
Authorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
| Authorized Official | RICHARDSON, KARA (ASSISTANT TREASURER) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: RICHARDSON, KARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 134,072 | $2.96M |
| 2019 | 147,999 | $3.06M |
| 2020 | 136,456 | $2.98M |
| 2021 | 186,212 | $3.62M |
| 2022 | 185,853 | $3.51M |
| 2023 | 176,996 | $3.80M |
| 2024 | 117,630 | $3.36M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 17,317 | 14,460 | $2.27M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 35,665 | 32,008 | $2.15M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 36,896 | 32,328 | $2.13M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21,153 | 18,379 | $1.28M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 27,476 | 10,831 | $801K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10,838 | 9,741 | $700K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8,030 | 7,247 | $644K |
| 70450 | Computed tomography, head or brain; without contrast material | 8,788 | 7,895 | $627K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,860 | 5,234 | $556K |
| 80053 | Comprehensive metabolic panel | 33,986 | 26,080 | $516K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 13,590 | 6,348 | $442K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5,261 | 3,692 | $373K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6,356 | 5,527 | $356K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 15,910 | 6,528 | $346K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 52,071 | 38,168 | $331K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5,958 | 5,289 | $323K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,238 | 3,891 | $322K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4,105 | 3,506 | $312K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,192 | 1,881 | $306K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 8,464 | 4,168 | $300K |
| 80047 | 12,754 | 11,505 | $288K | |
| 58661 | 256 | 217 | $281K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 13,814 | 6,968 | $265K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,261 | 2,961 | $253K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4,928 | 2,341 | $246K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,254 | 2,099 | $239K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,719 | 2,449 | $235K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,186 | 1,100 | $230K |
| G0378 | Hospital observation service, per hour | 8,557 | 7,330 | $222K |
| 84484 | 19,366 | 16,387 | $202K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 939 | 875 | $188K |
| 97161 | 5,163 | 4,672 | $178K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,361 | 3,867 | $176K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3,034 | 2,596 | $171K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,177 | 3,885 | $148K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4,183 | 3,891 | $145K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,482 | 4,036 | $135K |
| 84702 | 8,129 | 7,209 | $135K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 11,693 | 10,507 | $132K |
| 97535 | Self-care/home management training, each 15 minutes | 7,717 | 4,150 | $120K |
| 97162 | 3,143 | 2,926 | $116K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,587 | 1,467 | $114K |
| 83880 | 3,775 | 3,360 | $114K | |
| 93975 | 2,568 | 2,383 | $112K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,017 | 2,758 | $110K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,417 | 1,007 | $107K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,376 | 2,214 | $105K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,523 | 6,036 | $105K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 478 | 434 | $104K |
| 76642 | 2,673 | 2,180 | $97K | |
| 97116 | 5,924 | 3,152 | $95K | |
| 83690 | 16,145 | 13,983 | $94K | |
| 76830 | Ultrasound, transvaginal | 2,900 | 2,682 | $94K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,275 | 3,067 | $90K |
| 81025 | 9,079 | 8,213 | $88K | |
| 83735 | 15,881 | 11,313 | $82K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,672 | 3,457 | $82K |
| 82077 | 4,262 | 3,512 | $81K | |
| 82962 | 12,417 | 5,955 | $78K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 485 | 457 | $76K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,602 | 2,372 | $74K |
| 93356 | 657 | 602 | $71K | |
| 93971 | 2,311 | 2,095 | $71K | |
| 97165 | 2,392 | 2,136 | $67K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 914 | 852 | $60K |
| 86850 | 3,094 | 2,728 | $57K | |
| 81001 | 16,635 | 14,919 | $56K | |
| 83605 | 5,340 | 4,566 | $49K | |
| 82803 | 2,463 | 2,159 | $47K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 3,421 | 3,218 | $47K |
| 81003 | 9,416 | 8,610 | $44K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 19,960 | 15,962 | $40K |
| 71046 | Radiologic examination, chest; 2 views | 3,352 | 3,101 | $40K |
| 64483 | 309 | 238 | $40K | |
| 86900 | 3,860 | 3,424 | $39K | |
| 87040 | 2,787 | 2,252 | $37K | |
| 93970 | 824 | 768 | $37K | |
| 71250 | 1,160 | 1,091 | $36K | |
| 87077 | 2,737 | 2,477 | $34K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 345 | 311 | $34K |
| 87210 | 4,035 | 3,752 | $34K | |
| 84145 | 1,981 | 1,659 | $32K | |
| 80143 | 2,658 | 2,266 | $32K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 339 | 326 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,408 | 2,155 | $30K |
| 85379 | 3,732 | 3,382 | $30K | |
| 80076 | 3,830 | 3,460 | $30K | |
| 80179 | 2,514 | 2,157 | $30K | |
| 76801 | 2,641 | 2,335 | $29K | |
| 70486 | 874 | 822 | $28K | |
| 84703 | 3,213 | 2,912 | $28K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 256 | 245 | $27K |
| 93017 | 717 | 659 | $26K | |
| 97597 | 824 | 545 | $24K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 383 | 318 | $23K |
| 97166 | 761 | 714 | $23K | |
| 76770 | 499 | 460 | $23K | |
| 77066 | Tomosynthesis, mammo | 1,345 | 1,215 | $23K |
| 87186 | 3,048 | 2,791 | $23K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 296 | 260 | $23K |
| 85610 | 6,883 | 5,499 | $22K | |
| 64484 | 312 | 165 | $22K | |
| 70496 | 224 | 193 | $21K | |
| 87070 | 1,488 | 1,103 | $21K | |
| 82565 | 1,756 | 1,561 | $21K | |
| 70498 | 253 | 225 | $21K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 260 | 227 | $20K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 459 | 433 | $20K |
| 77062 | 1,044 | 947 | $19K | |
| 74018 | 1,360 | 1,158 | $19K | |
| 85730 | 3,839 | 3,316 | $18K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 30,621 | 26,060 | $18K |
| 77065 | Tomosynthesis, mammo | 1,100 | 929 | $17K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 310 | 279 | $16K |
| 58558 | 43 | 40 | $16K | |
| 85027 | 2,657 | 2,081 | $15K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 51 | 46 | $15K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 56 | 52 | $15K |
| 90715 | 702 | 657 | $15K | |
| 10060 | 181 | 167 | $14K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,447 | 2,131 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12,441 | 7,471 | $13K |
| 12001 | 199 | 179 | $13K | |
| 84112 | 154 | 130 | $12K | |
| 71045 | Radiologic examination, chest; single view | 19,144 | 16,884 | $12K |
| 87088 | 1,716 | 1,604 | $12K | |
| 51701 | 1,857 | 1,665 | $11K | |
| 72100 | 1,936 | 1,790 | $11K | |
| 19083 | 28 | 24 | $10K | |
| 86901 | 3,846 | 3,411 | $10K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,265 | 2,391 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,261 | 1,118 | $10K |
| 97035 | 787 | 377 | $9K | |
| 73630 | 2,404 | 2,130 | $9K | |
| 73221 | 110 | 94 | $8K | |
| 70491 | 95 | 82 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 788 | 676 | $8K |
| 84132 | 1,477 | 1,287 | $7K | |
| 96367 | 105 | 84 | $7K | |
| 82550 | 1,468 | 1,194 | $7K | |
| 77061 | 441 | 377 | $7K | |
| 86140 | 1,644 | 1,264 | $7K | |
| 87641 | 130 | 116 | $6K | |
| 73562 | 2,353 | 2,005 | $6K | |
| 82728 | 583 | 439 | $6K | |
| 87205 | 1,763 | 1,334 | $6K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 14 | 12 | $6K |
| 12011 | 69 | 65 | $5K | |
| Q3014 | Telehealth originating site facility fee | 553 | 467 | $5K |
| 85014 | 2,521 | 2,242 | $5K | |
| 73030 | 1,617 | 1,438 | $5K | |
| 52287 | 38 | 37 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 251 | 228 | $4K |
| 83986 | 279 | 255 | $4K | |
| 87075 | 629 | 426 | $4K | |
| 83615 | 882 | 684 | $4K | |
| 88307 | 539 | 461 | $4K | |
| 76536 | 99 | 97 | $4K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 76 | 70 | $4K |
| 80061 | Lipid panel | 366 | 326 | $4K |
| 92523 | 33 | 31 | $4K | |
| 87081 | 116 | 110 | $3K | |
| 72141 | 49 | 43 | $3K | |
| 83037 | 370 | 353 | $3K | |
| 73130 | 1,497 | 1,325 | $3K | |
| 82570 | 551 | 467 | $3K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,679 | 834 | $3K |
| 51798 | 527 | 486 | $3K | |
| Q0114 | Fern test | 421 | 372 | $3K |
| 96112 | 13 | 13 | $3K | |
| 82140 | 263 | 210 | $3K | |
| 73610 | 1,723 | 1,553 | $3K | |
| 78582 | 12 | 12 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 14,471 | 11,754 | $2K |
| 73502 | 499 | 448 | $2K | |
| 82435 | 100 | 93 | $2K | |
| 82731 | 26 | 26 | $2K | |
| 85652 | 949 | 762 | $2K | |
| 0399T | 67 | 62 | $2K | |
| 74170 | 12 | 12 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 34,426 | 26,889 | $2K |
| 74178 | 12 | 12 | $2K | |
| 82607 | 53 | 41 | $1K | |
| 90686 | 34 | 30 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 41 | 35 | $1K |
| 74183 | 21 | 15 | $1K | |
| 85461 | 138 | 128 | $1K | |
| 73110 | 696 | 625 | $1K | |
| 84156 | 304 | 244 | $975.47 | |
| 51741 | 12 | 12 | $955.81 | |
| 51729 | 14 | 13 | $870.13 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4,756 | 4,335 | $868.31 |
| 97163 | 34 | 30 | $865.47 | |
| 82271 | 29 | 27 | $852.72 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,449 | 1,280 | $829.65 |
| 96376 | 8,008 | 4,834 | $827.47 | |
| 93976 | 23 | 20 | $814.44 | |
| 77002 | 13 | 12 | $803.02 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 137 | 114 | $731.03 |
| 84460 | 150 | 116 | $662.06 | |
| 82330 | 61 | 55 | $600.09 | |
| 80164 | 75 | 67 | $594.82 | |
| 84550 | 112 | 96 | $580.01 | |
| 84450 | 113 | 89 | $520.06 | |
| 84295 | 100 | 93 | $476.20 | |
| 94060 | 12 | 12 | $462.22 | |
| 76870 | 27 | 24 | $452.55 | |
| 82947 | 98 | 91 | $409.11 | |
| 84439 | 53 | 51 | $400.94 | |
| 80320 | 771 | 660 | $391.10 | |
| 84520 | 100 | 93 | $390.44 | |
| 73564 | 30 | 26 | $383.09 | |
| 77080 | 27 | 24 | $375.02 | |
| 0240U | 13 | 13 | $326.78 | |
| A4648 | Tissue marker, implantable, any type, each | 191 | 169 | $321.30 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 927 | 860 | $312.87 |
| 36000 | 615 | 549 | $305.02 | |
| 82746 | 32 | 28 | $293.77 | |
| 88360 | 13 | 12 | $291.98 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 5,305 | 4,042 | $279.70 |
| 83550 | 43 | 39 | $274.32 | |
| 84100 | 84 | 53 | $268.81 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 16,048 | 12,674 | $265.75 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,750 | 7,366 | $253.54 |
| 87340 | 13 | 12 | $236.13 | |
| 83540 | 46 | 42 | $217.17 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 8,142 | 6,165 | $147.18 |
| J2704 | Injection, propofol, 10 mg | 14,595 | 9,618 | $128.55 |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 12 | 12 | $126.44 |
| 94729 | 12 | 12 | $123.94 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 540 | 390 | $109.61 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15,366 | 13,068 | $109.51 |
| 73590 | 150 | 132 | $98.01 | |
| 90674 | 37 | 33 | $98.00 | |
| 80329 | 48 | 39 | $95.59 | |
| 36415 | Collection of venous blood by venipuncture | 9,556 | 6,088 | $91.90 |
| J1170 | Injection, hydromorphone, up to 4 mg | 8,660 | 5,618 | $83.40 |
| 87147 | 15 | 13 | $74.90 | |
| 85018 | 36 | 26 | $63.09 | |
| 88304 | 535 | 493 | $58.86 | |
| 73080 | 101 | 91 | $53.78 | |
| 71101 | 30 | 28 | $50.82 | |
| 51784 | 14 | 13 | $47.67 | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 899 | 713 | $43.75 |
| 72070 | 87 | 82 | $37.86 | |
| C1769 | Guide wire | 1,528 | 1,377 | $33.50 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,384 | 1,233 | $21.73 |
| C9113 | Injection, pantoprazole sodium, per vial | 1,885 | 1,092 | $20.10 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 6,436 | 4,927 | $18.98 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 5,983 | 4,804 | $18.87 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,738 | 5,964 | $15.94 |
| J7050 | Infusion, normal saline solution, 250 cc | 4,541 | 2,545 | $13.48 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,608 | 4,847 | $12.44 |
| 88302 | 211 | 181 | $12.12 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,535 | 2,301 | $9.81 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 18,479 | 14,591 | $7.82 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 6,187 | 5,010 | $7.50 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 5,090 | 2,048 | $6.68 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 544 | 383 | $6.60 |
| J1644 | Injection, heparin sodium, per 1000 units | 5,642 | 1,934 | $6.20 |
| J1815 | Injection, insulin, per 5 units | 6,867 | 2,221 | $5.97 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 3,202 | 2,812 | $2.49 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 624 | 485 | $0.02 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 2,238 | 1,919 | $0.01 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,731 | 1,292 | $0.00 |
| A6403 | Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing | 419 | 380 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,594 | 1,207 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 1,802 | 1,668 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 75 | 68 | $0.00 |
| A4565 | Slings | 243 | 234 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 309 | 95 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 248 | 233 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 281 | 251 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 237 | 208 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 325 | 288 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 947 | 817 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,227 | 472 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 136 | 83 | $0.00 |
| C1758 | Catheter, ureteral | 171 | 146 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 403 | 321 | $0.00 |
| C1729 | Catheter, drainage | 18 | 12 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 258 | 182 | $0.00 |
| 86923 | 15 | 13 | $0.00 | |
| 29125 | 42 | 39 | $0.00 | |
| 73140 | 55 | 51 | $0.00 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 15 | 13 | $0.00 |
| C1776 | Joint device (implantable) | 28 | 28 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 169 | 113 | $0.00 |
| 36600 | 44 | 42 | $0.00 | |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | 60 | 14 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 13 | 12 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 844 | 764 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 1,370 | 1,187 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 2,710 | 1,456 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,962 | 1,785 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,066 | 3,000 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 579 | 493 | $0.00 |
| 36410 | 21 | 20 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 254 | 239 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 4,296 | 3,230 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 157 | 140 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 543 | 472 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 462 | 430 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 356 | 180 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 561 | 486 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 201 | 160 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 1,077 | 504 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 361 | 251 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 189 | 157 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 50 | 43 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 353 | 85 | $0.00 |
| J3590 | Unclassified biologics | 406 | 127 | $0.00 |
| 94644 | 18 | 12 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 106 | 93 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 176 | 109 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 97 | 91 | $0.00 |
| 88342 | 118 | 109 | $0.00 | |
| A9567 | Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries | 12 | 12 | $0.00 |
| A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | 12 | 12 | $0.00 |
| 73090 | 35 | 27 | $0.00 | |
| J3360 | Injection, diazepam, up to 5 mg | 52 | 44 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 90 | 84 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 54 | 42 | $0.00 |
| 51797 | 12 | 12 | $0.00 | |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 17 | 15 | $0.00 |
| 72170 | 14 | 13 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 24 | 13 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 110 | 19 | $0.00 |
| A4364 | Adhesive, liquid or equal, any type, per oz | 13 | 12 | $0.00 |